| Literature DB >> 25276059 |
Eman Abu-Gharbieh1, Fatehia A Bayoumi2, Naglaa G Ahmed3.
Abstract
The aim of the study was to evaluate the potential protective effect of ozonized olive oil (OZO) in 2,4-dinitrobenzene sulphuric acid (DNBS) induced colitis in rats and to elucidate the role of some antioxidant defense system (superoxide dismutase "SOD," glutathione peroxidase "GSH-Px," and catalase "CAT") in these effects. The physicochemical parameters including viscosity, peroxide, and acid values of olive oil and OZO were evaluated. The animals were divided into several groups and the colitis was induced in the rats by intracolonic instillation of DNBS at dose of 15 mg/rat. Olive oil (OO) at dose of 6 mg/kg and OZO at doses of 3 and 6 mg/kg was administered orally for 7 days, starting the day before induction of colitis. Our results showed that macroscopic and microscopic damage scores were significantly reduced in a dose response manner in rats pretreated with OZO only. In contrast, CAT, GSH-Px, and SOD activities were significantly increased in the distal colon of inflamed animals pretreated with OZO with respect to control group dose dependently. Results demonstrate that OZO pretreatment exerts protective effects in DNBS induced colitis in rats and provide evidence that the protective effects of OZO are mediated by stimulation of some antioxidant enzymes.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25276059 PMCID: PMC4168156 DOI: 10.1155/2014/967205
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
The physicochemical parameters of olive oil and ozonized olive oil.
| Item | Olive oil | Ozonized olive oil |
|---|---|---|
| Colour | Dark green | Yellowish white |
| Viscosity cP | 8500 | semisolid |
| Peroxide value | 1.33 | 400 |
| Acid value | 1% | 14.6% |
Figure 1Body weight change in the different experimental groups. Data are expressed as mean values ± SEM. n = 6 rats per group. Statistical analysis was performed with Two-Way ANOVA; ∗ and # P values are less than 0.05 and 0.01, respectively versus inflamed group; **P < 0.01 versus control group.
Macro and microscopic damage scores for the animal groups.
| Treatment | Noninflamed (intrarectal vehicle) | Inflamed (intrarectal DNBS 15 mg per rat) | |||||
|---|---|---|---|---|---|---|---|
| Nontreated | OO (6 mg/kg) | OZO (6 mg/kg) | Nontreated | OO (6 mg/kg) | OZO (3 mg/kg) | OZO (6 mg/kg) | |
| Macroscopic score | 1.20 ± 0.12 | 1.11 ± 0.22 | 1.13 ± 0.16 | 7.5 ± 0.41a | 7.4 ± 0.35 | 5.56 ± 0.15b | 3.52 ± 0.22b |
| Microscopic score | 0.42 ± 0.13 | 0.38 ± 0.25 | 0.41 ± 0.28 | 4.52 ± 0.21a | 4.31 ± 0.42 | 3.20 ± 0.27b | 3.00 ± 0.24c |
a P < 0.001 versus intrarectal vehicle and b and c P < 0.05 and 0.01 versus inflamed non-treated group respectively.
Macroscopic assessment criteria: presence of adhesions (0–2), faecal material consistency (0–2), bowel thickness (mm), presence and extension of hyperaemia (0–6).
Microscopic assessment criteria: degree of mucosal architecture loss (0–3), cellular infiltration (0–3), muscle thickening (0–3), presence of crypt abscess and goblet cell depletion (0-1).
Figure 2Histopathological findings of colonic tissues from different animals' groups; (a) colonic tissue for animals treated with OO shows normal surface epithelium and crypt cells ×400. (b) Colonic tissue for animals treated with high dose OZO alone with normal surface epithelium and crypt cells ×200. (c) Inflamed control group; the mucosa shows focal loss of the covering and lamina propria shows dense lymphoplasmacytic and histiocytic infiltrate to the submucosa ×200. (d) Inflamed animals treated with OO; mononuclear granulomatous infiltrate encroaching on the overlying mucosa with apparent destruction of the muscularis mucosa and mucosal covering ×200. (e) Inflamed animals treated with low dose OZO nearly normal mucosa and submucosa with polypoid formation. Crypt cell hyperplasia and elongation. Lamina propria is infiltrated by monocytes and eosinophils 400x. (f) Inflamed animals treated with high dose OZO, showing normal mucosal lining and submucosa and cellular infiltrate with eosinophils 200x.
Effects of OO and OZO in noninflamed and inflamed rats.
| Treatment | Noninflamed (intrarectal vehicle) | Inflamed (intrarectal DNBS 15 mg per rat) | |||||
|---|---|---|---|---|---|---|---|
| Nontreated | OO (6 mg/kg) | OZO (6 mg/kg) | Nontreated | OO (6 mg/kg) | OZO (3 mg/kg) | OZO (6 mg/kg) | |
| GSH-Px U/g prot. | 1.29 ± 0.14 | 2.09 ± 0.37 | 2.9 ± 0.26 | 0.75 ± 0.11d | 0.76 ± 0.14 | 0.84 ± 0.13a | 1.22 ± 0.15b |
| CAT (KU/gr prot.) | 493.48 ± 11.87 | 523.23 ± 18.04 | 541 ± 19.65 | 366.40 ± 17.52d | 384.85 ± 11.16 | 431.88 ± 22.72 | 487.12 ± 17.79c |
| SOD (U/g) | 62.50 ± 5.44 | 72.41 ± 9.35 | 74.52 ± 6.24 | 49.33 ± 3.16d | 56.75 ± 2.35 | 69.01 ± 0.19a | 78.67 ± 3.71b |
| TBARS (nmol/g prot.) | 0.056 ± 0.10 | 0.042 ± 0.26 | 0.12 ± 0.09 | 0.67 ± 0.30d | 0.632 ± 0.26 | 0.619 ± 0.32 | 0.624 ± 0.18 |
a, b, and c P < 0.01, 0.001, 0.05, respectively, versus inflamed nontreated group.
d P < 0.05 versus intrarectal vehicle.